CRGX

CARGO Therapeutics, Inc. Common Stock (CRGX)

US
$ 22.343.96%

Price Chart

Key Statistics

Market Cap
$ 199.2M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
142.39K
52W High
$ 25.45
52W Low
$ 3.00
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
4.1579
200-Day MA
13.1291
52 Week High
25.45
52 Week Low
3

About CRGX

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

Employees
167
Headquarters
San Mateo, CA
CEO
Mr. Anup Radhakrishnan

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg